SecSonar.com

Alumis Inc. Common Stock (ALMS)

Alumis Inc. Common Stock at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Alumis Inc. Common Stock (ALMS) is a Biotechnology company based in US with a market capitalization of $2.7B. Free cash flow was negative at -$370.2M. This page tracks ALMS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 168 employees · IPO Feb 22, 2021

Valuation

Valuation & price

$22.87 · as of May 17, 2026 · -23.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

8.81

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$29.98$16.64$3.31Jul 25Dec 25Jun 26Jul 7, 25$3.31Jul 9, 25$3.50Jul 11, 25$3.52Jul 15, 25$3.49Jul 17, 25$3.51Jul 21, 25$3.32Jul 23, 25$3.84Jul 25, 25$3.88Jul 29, 25$3.95Jul 31, 25$4.14Aug 4, 25$4.09Aug 6, 25$4.37Aug 8, 25$4.30Aug 12, 25$4.46Aug 14, 25$4.39Aug 18, 25$4.85Aug 20, 25$4.41Aug 22, 25$4.84Aug 27, 25$4.92Aug 29, 25$4.64Sep 3, 25$4.68Sep 5, 25$4.51Sep 9, 25$4.27Sep 11, 25$4.36Sep 15, 25$4.38Sep 17, 25$4.13Sep 19, 25$4.17Sep 23, 25$4.10Sep 25, 25$3.99Sep 29, 25$3.95Oct 1, 25$4.06Oct 3, 25$4.02Oct 7, 25$4.51Oct 9, 25$4.53Oct 13, 25$4.61Oct 16, 25$4.61Oct 20, 25$4.76Oct 22, 25$4.49Oct 24, 25$4.51Oct 28, 25$4.81Oct 30, 25$4.66Nov 3, 25$4.56Nov 5, 25$4.57Nov 7, 25$4.72Nov 11, 25$5.30Nov 13, 25$5.28Nov 17, 25$5.58Nov 19, 25$6.57Nov 21, 25$7.30Nov 25, 25$7.33Nov 28, 25$7.67Dec 2, 25$7.41Dec 5, 25$11.12Dec 9, 25$11.43Dec 11, 25$11.61Dec 15, 25$11.31Dec 17, 25$10.58Dec 19, 25$11.29Dec 23, 25$11.45Dec 26, 25$10.97Dec 30, 25$9.88Jan 2, 26$8.96Jan 6, 26$16.23Jan 8, 26$18.18Jan 12, 26$21.09Jan 14, 26$24.34Jan 16, 26$23.86Jan 21, 26$26.68Jan 23, 26$24.52Jan 28, 26$27.71Jan 30, 26$24.51Feb 3, 26$27.04Feb 5, 26$26.34Feb 9, 26$26.12Feb 11, 26$25.63Feb 13, 26$26.54Feb 18, 26$27.51Feb 20, 26$27.97Feb 24, 26$28.08Feb 26, 26$29.98Mar 2, 26$29.72Mar 4, 26$28.87Mar 6, 26$26.90Mar 10, 26$28.10Mar 12, 26$25.03Mar 16, 26$26.20Mar 19, 26$25.38Mar 23, 26$23.36Mar 25, 26$24.81Mar 27, 26$24.80Mar 31, 26$22.03Apr 2, 26$23.37Apr 7, 26$22.31Apr 9, 26$22.94Apr 13, 26$22.52Apr 15, 26$24.16Apr 17, 26$24.99Apr 21, 26$24.98Apr 23, 26$25.99Apr 27, 26$24.75Apr 29, 26$22.89May 1, 26$25.18May 5, 26$26.13May 8, 26$23.66May 12, 26$23.51May 14, 26$24.63May 18, 26$21.15May 20, 26$22.04May 22, 26$22.02May 27, 26$21.33May 29, 26$21.60Jun 2, 26$20.04Jun 4, 26$20.39Jun 8, 26$18.99Jun 10, 26$20.06Jun 12, 26$24.15Jun 16, 26$22.32Jun 18, 26$23.41Jun 23, 26$24.51Jun 29, 26$26.95
$3.3152-week range$29.98
Loading valuation history…

Fundamentals

Key fundamentals

$2.7B

Market cap

—

Revenue growth (YoY)

85.5%

Gross margin

-$370.2M

Free cash flow (USD)

-$271.6M

Net debt

Net cash position

2900.2%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2022 → 2025

FY 2022$0.00FY 2023$0.00FY 2024$0.00FY 2025$24.1M
$0$24.1M

Free cash flow by year

2022 → 2025

FY 2022$-110.1MFY 2023$-134.5MFY 2024$-256.8MFY 2025$-370.2M
-$110.1M-$370.2M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.74)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJul 2, 2026Filing
  • 8-K eventClinical Pipeline UpdateJun 29, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing

Questions

Frequently asked questions

What is Alumis Inc. Common Stock's market cap?

Alumis Inc. Common Stock (ALMS) has a market capitalization of $2.7B.

What is ALMS's P/E ratio?

A meaningful P/E ratio is not available for ALMS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ALMS's price-to-book (P/B) ratio?

ALMS trades at 8.81 times book value per share.

When did Alumis Inc. Common Stock last report earnings?

ALMS last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying ALMS stock?

SEC Form 4 filings show no open-market insider buys at Alumis Inc. Common Stock in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ARQT

Arcutis Biotherapeutics, Inc.

$2.7B

IDYA

IDEAYA Biosciences, Inc.

$2.6B

TARS

Tarsus Pharmaceuticals, Inc.

$2.6B

RCUS

Arcus Biosciences, Inc.

$2.5B

ADPT

Adaptive Biotechnologies Corporation

$2.5B

TNGX

Tango Therapeutics, Inc.

$2.4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.